research learn today sell side lunch sentiment indic neutral host sell-sid lunch today focu continu primarili around spin announc made earn yesterday highlight post-earn note debat introduc easi ownstock maintain sp lower price target link strategic/oper logic transact sound align recent trend pharma peer inject debat otherwis rel clean stori one liner think stock rang bound near-term import questions/takeaway plan address increas keytruda concentr transact chang bd strategy/ manag well awar keytruda concentr risk pushback well ep backfil busi develop alway focu appear stronger sens urgenc add portfolio deal diversifi core asset base need done yesterday said manag also note spin chang think capit deploy chang firepow abil transact compani said oncolog target-rich therapeut area remain focus across therapeut area includ potenti expand new area ep backfil remain key focu per analysi assum half newco proce deploy toward share repurchas stand-alone ep oper effici captur standup cost offset million standup cost captur dissynergi separ two compani effici deriv sg well littl bit primarili back offic oper discoveri cog commerci infrastructur newco larg alreadi establish standup cost funnel toward build corpor infrastructur addit augment capabl newco grow busi flat declin within manag indic declin busi captur loss exclus loe nuvar continu impact zetia japan two factor adjust busi would flat slightli grow goe busi larg move impact augment growth biosimilar busi grow high doubl digit well invest legaci brand ie pain derm previous limit invest could return growth much inorgan growth opportun newco accordingtomanag lowsingledigitgrowthoutlookfornewcoexcludesbdopportun particularli around women see lot opportun becom consolid commerci partner point asset women variou phase develop point newco commerci infrastructur leverag commerci partner compani quickli launch product global final spin remain will invest behind busi meaning opportunitiesthatariseandmorecolorandfinancialsaroundnewco ie legacybrand isexpectedintothesummer/fal move piec key product keytruda gardasil softer expect sever push pull keytruda includ japan call call saw price reduct februari anoth expect april similar magnitud saw hospitals/wholesal reduc inventori hand anticip reduct compani expect impact also affect potenti though compani believ grow overal japan price adjust eu also call ii gardasil million reduct sale due borrow cdc stockpil highlight supply-constrain go year still expect growthbuttemperedrelativetorecentyear particularlyasitfocusesonmeetingousdemand compani nameexchangetickerratingrisk qualifierpric targetcurrencypricepric datemerck co inc nyse ussector performnot feb et capit market llc randal stanicki capit market llc ashley ryu daniel busbi edwin delfin click conflict interest disclosur relat merck co inc randal stanicki disclosur also avail send written request capit market research publish bay street royal bank plaza floor south tower toronto ontario email right reserv materi may publish broadcast rewritten redistribut form pleas click legal restrict term use applic site use site signifi agreement term use
